HemaCell is based in Stanford, California. It has raised $57M in total funding. Latest round: Series B.
HemaCell funding overview
HemaCell is based in Stanford, California. HemaCell has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2026. The round record for HemaCell runs through 2026; nothing later has been disclosed. Investors on record include Shenzhen Capital Group (SCGC), Hebei Industrial Investment Fund, CDH Investments, Wedo Venture Capital, Lucion Venture Capital, Founder H Fund and 6 others. 12 distinct backers are named across the disclosed rounds.
HemaCell at a glance
Total raised
$57M
Latest round
Series B
Latest round date
June 2026
Headquarters
Stanford, California
Notable investors
Shenzhen Capital Group (SCGC), Hebei Industrial Investment Fund, CDH Investments, Wedo Venture Capital, Lucion Venture Capital, Founder H Fund, Laurel Venture Capital, Tairong Venture Capital
Frequently asked about HemaCell funding
How much has HemaCell raised?
HemaCell has raised $57M in total disclosed funding across the rounds on record.
Who has invested in HemaCell?
Shenzhen Capital Group (SCGC), Hebei Industrial Investment Fund, CDH Investments, Wedo Venture Capital, Lucion Venture Capital, Founder H Fund are named among the investors backing HemaCell.
What was the latest HemaCell funding round?
The most recent disclosed round is a Series B, announced in June 2026.
Where is HemaCell based?
HemaCell is based in Stanford, California.
When did HemaCell last raise?
The last disclosed HemaCell round closed in June 2026 at Series B.
Every HemaCell figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Stanford at a similar stage.
